| Sep 20 2023 |
Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum Monthly Cap on Cost-Sharing Payments Program |
Mintz |
| Sep 20 2023 |
Mintz IRA Update — Legal Challenges to the Medicare Drug Price Negotiation Program |
Mintz |
| Sep 20 2023 |
There’s One for You, Nineteen for Me: IRS Issues Guidance on 1900% Pharmaceutical Excise Tax |
ArentFox Schiff LLP |
| Sep 20 2023 |
Mintz IRA Update — A Deeper Dive into Other Controversies of the IRA’s Medicare Drug Price Negotiation Program |
Mintz |
| Sep 20 2023 |
To Reschedule or to Deschedule: That Is the (Marijuana) Question |
Bradley Arant Boult Cummings LLP |
| Sep 19 2023 |
Top Takeaways | Specialty Spotlight: Gastroenterology |
McDermott Will & Schulte LLP |
| Sep 19 2023 |
Mississippi Half-Step Uptown Toodeloo: Department of Health Proposes Robust Revisions to Medical Cannabis Regulations |
Bradley Arant Boult Cummings LLP |
| Sep 19 2023 |
Key Takeaways | What the Money Thinks: Investing in Innovative Care Delivery |
McDermott Will & Schulte LLP |
| Sep 19 2023 |
FDA: Approval for PTSD MDMA-Assisted Therapy Is One Step Closer |
Foley & Lardner LLP |
| Sep 19 2023 |
Senators Again Urge Enforcement of Dairy Standards of Identity |
Keller and Heckman LLP |
| Sep 19 2023 |
Do Corporate Boards Necessarily Breach Their Fiduciary Duties When They Approve Illegal Conduct? |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Sep 19 2023 |
FDA Announces and Seeks Comments on Cosmetics Direct — Portal for Cosmetic Facility Registration and Product Listing |
ArentFox Schiff LLP |
| Sep 18 2023 |
Third Circuit Finds Documentation Issues May Be “Material” under the FCA |
Bradley Arant Boult Cummings LLP |
| Sep 18 2023 |
Report to Congress Identifies Significant Implications of Marijuana Rescheduling |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Sep 18 2023 |
Federal Trade Commission Warns Against Improper Orange Book Listings |
Foley & Lardner LLP |
| Sep 15 2023 |
McDermottPlus Check-Up: September 15, 2023 |
McDermott Will & Schulte LLP |
| Sep 15 2023 |
California Senate Passes AB 418 |
Keller and Heckman LLP |
| Sep 14 2023 |
California Fast Food Workers Look Forward to Pay Increases |
Vedder Price |
| Sep 14 2023 |
Research Finds Calories Often Absent from Food Delivery Platforms |
Keller and Heckman LLP |
| Sep 14 2023 |
Stark Integrity Podcast: FCA, CARES Act, and Call Arrangements Episodes [Podcast] |
Nelson Mullins |
| Sep 14 2023 |
NNCO Will Host Symposium on “Enabling the Nanotechnology Revolution” on October 10, 2023 |
Bergeson & Campbell, P.C. |
| Sep 14 2023 |
Key Takeaways | Hospital and Health System Digital Health Spotlight: It’s all About the Patient! |
McDermott Will & Schulte LLP |
| Sep 14 2023 |
Back to FAST Recovery: Business and Labor Reach Agreement |
Jackson Lewis P.C. |
| Sep 13 2023 |
FDA Sponsors Workshops on the Use of Meta-Analyses in Nutrition Research and Policy |
Keller and Heckman LLP |
| Sep 13 2023 |
Sua Sponte State Law Certification in Opioid MDL Appeal |
Squire Patton Boggs (US) LLP |
| Sep 12 2023 |
HHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness |
Epstein Becker & Green, P.C. |
| Sep 12 2023 |
It’s Time to Move On: Litigation Regarding Alabama Medical Cannabis Commission Needs to Come to a Head |
Bradley Arant Boult Cummings LLP |
| Sep 12 2023 |
Another Heavy Metal Lawsuit Dismissed |
Keller and Heckman LLP |
| Sep 11 2023 |
DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information |
Foley & Lardner LLP |
| Sep 11 2023 |
Old North State Report – Sept. 11, 2023 |
Nelson Mullins |
| Sep 11 2023 |
FDA Issues Draft Guidance on Best Practices for Selecting Predicate Devices for 510(k) Notifications |
ArentFox Schiff LLP |
| Sep 11 2023 |
California Steps Up Liquor License Enforcement |
McDermott Will & Schulte LLP |
| Sep 8 2023 |
DOE and NSF Select Three Projects to Accelerate Biomanufacturing Innovation and Advance the U.S. Bioeconomy |
Bergeson & Campbell, P.C. |
| Sep 8 2023 |
Food & Chemicals Unpacked: The Notorious NAD: Challenge Accepted? |
Keller and Heckman LLP |
| Sep 8 2023 |
California Senate Removes Titanium Dioxide from AB 418 List of Prohibited Substances |
Keller and Heckman LLP |
